ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 572

Anti-Periodontal Bacteria Antibody Titers Are Inversely Correlated with ACPA in RA-Free Individuals with Periodontal Disease Compared to Community Controls

Emma Weeding1, Londyn Robinson2, Jeremy Sokolove3, Julie Marchesan4, Steven Offenbacher4, William H. Robinson3, Ryan Demmer5, Bryan Michalowicz6 and Jerry A. Molitor7, 1Department of Internal Medicine, University of Michigan, Ann Arbor, MI, 2University of Minnesota, Minneapolis, MN, 3Stanford University School of Medicine, Stanford, CA, 4Department of Periodontology, Dental School, University of North Carolina at Chapel Hill, Chapel Hill, NC, 5Epidemiology, Columbia University Mailman School of Public Health, New York, NY, 6Department of Developmental and Surgical Sciences, University of Minnesota, Minneapolis, MN, 7Rheumatic/Autoimmune Diseases, University of Minnesota, Minneapolis, MN

Meeting: 2016 ACR/ARHP Annual Meeting

Date of first publication: September 28, 2016

Keywords: ACPA, microbiome, pathogenesis and rheumatoid arthritis (RA), Periodontitis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 13, 2016

Title: Rheumatoid Arthritis – Human Etiology and Pathogenesis - Poster I

Session Type: ACR Poster Session A

Session Time: 9:00AM-11:00AM

Background/Purpose: Rheumatoid arthritis (RA) and periodontal disease (PD) are comorbid conditions that share multiple underlying risk factors and pathophysiological features. A dysbiotic periodontal microbiome might be an environmental trigger for RA, though the underlying mechanisms remain unclear. Several studies have focused on the ability of Porphyromonas gingivalis (Pg) to citrullinate human α-enolase, suggesting a direct relationship between periodontal bacteria and the development of serological autoimmunity, and possibly eventual autoimmune disease. We investigated the associations between 18 anti-citrullinated peptide antibodies (ACPAs) and antibodies to 18 species of periodontal bacteria in RA-free individuals with and without PD.

Methods: Adults with moderate to severe periodontal disease as defined by the 2000 American Academy of Periodontology definitions and no history of RA or RA symptoms were recruited for the PD group (n = 181). Periodontally healthy controls matched for age and sex were selected from the dental Atherosclerosis Risk in Communities (ARIC) cohort (n = 138). Serum anti-periodontal bacteria antibodies were measured using a rapid checkerboard immunoblotting technique. Analysis of ACPAs was performed using a multiplex assay platform. Linear regression models were used to examine the relationships between PD bacteria antibody titers and ACPA positivity while controlling for age, sex, and smoking status.

Results: Total number of ACPAs was equivalent between the PD and control groups, with 34% having at least one ACPA, and 7% having three or more ACPAs. For all but one PD bacterial species, antibody titers were significantly higher in the PD group compared to controls. Within the PD group, having a total of three or more ACPAs was generally associated with decreased anti-bacteria antibody titers including for Pg, Tannerella forsythia, and Treponema denticola (Td), though this reached statistical significance only with Td and marginally (p = 0.09). These trends were not seen with Prevotella species in the PD group, and were generally reduced or absent in the control group. Certain specific ACPAs were more strongly associated with decreased anti-bacterial antibody titers than others. Most notably, significantly decreased Td antibodies were associated with clusterin ACPA positivity (p < 0.05), and marginally with biglycan, fibrinogenA, and histone 2A ACPA positivity (all p-values < 0.10) in the PD group. Similar trends were seen with Pg across multiple ACPAs, and enolase across multiple bacterial species, but were generally weaker. There was no correlation between Pg antibody titers and enolase.

Conclusion: Relationships between ACPAs and PD bacteria antibody titers were predominantly inverse though largely not statistically significant in this small sample. The strongest relationships were found between distinct individual ACPAs and Td antibodies; results for Pg and enolase were relatively weak. Our results suggest an interplay between aberrant immune response to periodontal bacteria and serological autoimmunity, and have implications for future study of P. gingivalis and T. denticola as possible inciting factors of RA.


Disclosure: E. Weeding, None; L. Robinson, None; J. Sokolove, Abbvie, 3; J. Marchesan, None; S. Offenbacher, None; W. H. Robinson, None; R. Demmer, None; B. Michalowicz, None; J. A. Molitor, Pfizer Inc, 2.

To cite this abstract in AMA style:

Weeding E, Robinson L, Sokolove J, Marchesan J, Offenbacher S, Robinson WH, Demmer R, Michalowicz B, Molitor JA. Anti-Periodontal Bacteria Antibody Titers Are Inversely Correlated with ACPA in RA-Free Individuals with Periodontal Disease Compared to Community Controls [abstract]. Arthritis Rheumatol. 2016; 68 (suppl 10). https://acrabstracts.org/abstract/anti-periodontal-bacteria-antibody-titers-are-inversely-correlated-with-acpa-in-ra-free-individuals-with-periodontal-disease-compared-to-community-controls/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2016 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/anti-periodontal-bacteria-antibody-titers-are-inversely-correlated-with-acpa-in-ra-free-individuals-with-periodontal-disease-compared-to-community-controls/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology